Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol.

<h4>Background</h4>Polycystic ovary syndrome (PCOS) is a common gynecological disease that is often accompanied by some metabolic abnormality such as insulin resistance and dyslipidemia. As a non-pharmacological therapy, acupuncture is widely used for the treatment of PCOS, but the effec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang Wu, Tao Peng, Yu Chen, Li Huang, Bisong He, Shaobin Wei
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/023eb4f71aec45478bfa3ce8dcb969dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:<h4>Background</h4>Polycystic ovary syndrome (PCOS) is a common gynecological disease that is often accompanied by some metabolic abnormality such as insulin resistance and dyslipidemia. As a non-pharmacological therapy, acupuncture is widely used for the treatment of PCOS, but the effectiveness for insulin resistance and lipid metabolic disorder remains controversial.<h4>Objectives</h4>To assess the effectiveness and safety of acupuncture for insulin resistance and lipid metabolic disorder of women with PCOS.<h4>Search methods</h4>Eight databases will be searched from inception to June 2021, three clinical trial registration platforms will be searched for relevant trials.<h4>Selection criteria</h4>Randomized controlled trials (RCTs) of acupuncture therapy for insulin resistance and lipid metabolic of PCOS will be included.<h4>Data collection and analysis</h4>Study screening, data collection, and analysis will be performed by two or more reviewers independently. We will calculate mean difference (MD), standard mean difference (SMD) with 95% confidence intervals (CIs). Data synthesis will be performed with RevMan V.5.3 software and with Stata V.15.0 software when necessary.<h4>Prospero registration number</h4>CRD42020177846.